CCL2 and inflammatory bowel disease: While the biological role of CCL2 in CD and IBD is well recognized (Maharshak et al., 2010; Martin et al., 2019; Darkoh et al., 2014), the results from genetic association studies are not consistent, and the disease outcomes could potentially differ by population studied (Chen et al., 2016).